Life Science Outsourcing Hires Doug Constable as CEO

Life Science Outsourcing (LSO), a contract manufacturer and value-added service provider to medical device and life science companies, has named Doug Constable as its new CEO.

Constable boasts over three decades of leadership experience in medtech. He was most recently CEO of Clayens North America, a precision plastics and metal solutions provider. During his tenure, he led the company’s growth into U.S. and Mexican markets. Constable has successfully guided over 40 strategic transactions over his career, according to LSO.

The company celebrates this during its next growth phase, as it expands its end markets and service offerings under the ownership of PPC Enterprises. Earlier this year, LSO acquired manufacturing assets from a precision microfluidic and diagnostic manufacturing company, building on its 2023 acquisition of J-Pac Medical.

“Doug understands the opportunities ahead for LSO and the customers we serve,” said Asif Zaman, Partner and Head of Healthcare Services at PPC. “His leadership will help accelerate our growth and strengthen LSO’s position as a trusted partner to innovative medical device and life science companies worldwide.”

Constable said he’s honored to step into the new role at LSO and is energized by its opportunities ahead.

“With the company positioned for rapid growth and continued success, it’s a privilege to help lead us into this next chapter,” he said. “LSO has built a longstanding reputation for quality, expertise and excellence in medical device contract manufacturing. I am deeply committed to upholding those standards as we expand our capabilities and reach.”

“Doug has a long history of driving operational excellence and strong business performance,” said John Morgan, Operating Partner at PPC. “His experience leading and scaling complex manufacturing organizations will be invaluable as LSO continues to grow and expand its capabilities across the medical device and life science markets.”